Vistagen Therapeutics (VTGN) Stock Price & Financial Analysis
Vistagen Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Vistagen Therapeutics
What is the current stock price for VTGN?
As of the latest trading session, VTGN stock trades at $0.59. The 52-week range is $0.43–$5.14, with a day range of $0.59–$0.61.
What is the P/E ratio for VTGN?
The P/E ratio (Price-to-Earnings) for VTGN is shown in the Key Statistics section. This valuation metric helps compare Vistagen Therapeutics, Inc. to industry peers.
Does VTGN pay dividends?
Vistagen Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for VTGN?
Analyst ratings and recommendations for VTGN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of VTGN?
Vistagen Therapeutics's market capitalization is $24.8M, classifying it as a micro-cap company. Vistagen Therapeutics operates in the Healthcare sector within the Biotechnology industry.